Literature DB >> 26617724

Expression of RKIP, E-cadherin and NF-kB p65 in esophageal squamous cell carcinoma and their correlations.

Fu-Min Ping1, Gui-Jing Liu1, Zhi-Jun Liu1, Hai-Bin Li1, Jian-Wen Zhai1, Shu-Xia Li1, Yue-Mei Liu1, Bao-Wei Li1, Hong Wei1.   

Abstract

To detect the expression of RKIP, E-cadherin and NF-kB p65 in esophageal squamous cell carcinoma (ESCC) and study their correlations. Steptavidin-peroxidase (S-P) method was employed to detect the expressions of RKIP, E-cadherin and NF-kB p65 in ESCC tissues from 77 cases and paracancerous tissues from 77 cases. The correlations between their expressions and clinicopathological indices and between the expressions of these proteins themselves were analyzed. The expressions of RKIP and E-cadherin in ESCC tissues were obviously lower than those in the paracancerous tissues (P<0.01); the expressions in ESCC tissues from cases with lymph node metastasis were lower than those from cases without lymph node metastasis (P<0.01); the expression of RKIP was positively correlated with the expression of E-cadherin in ESCC tissues (P<0.01). The expression of NF-kB p65 in ESCC tissues was correlated with clinical staging, lymph node metastasis and tumor differentiation (P<0.01); the expression of RKIP was negatively correlated with the expression of NF-kB p65 in ESCC tissues (P<0.05). Downregulation or depletion of RKIP was related to the onset and progression of ESCC, and facilitated the invasion and metastasis of ESCC by downregulating E-cadherin and upregulating NF-kB p65.

Entities:  

Keywords:  E-cadherin; Esophageal squamous cell carcinoma (ESCC); NF-kB p65; RKIP

Mesh:

Substances:

Year:  2015        PMID: 26617724      PMCID: PMC4637539     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin.

Authors:  E Janda; M Nevolo; K Lehmann; J Downward; H Beug; M Grieco
Journal:  Oncogene       Date:  2006-06-05       Impact factor: 9.867

2.  Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition.

Authors:  Sung-Young Shin; Oliver Rath; Armin Zebisch; Sang-Mok Choo; Walter Kolch; Kwang-Hyun Cho
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

3.  Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients.

Authors:  Giuseppe Portale; Jeffrey A Hagen; Jeffrey H Peters; Linda S Chan; Steven R DeMeester; Tasha A K Gandamihardja; Tom R DeMeester
Journal:  J Am Coll Surg       Date:  2006-04       Impact factor: 6.113

4.  Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.

Authors:  Parham Minoo; Inti Zlobec; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Journal:  Am J Clin Pathol       Date:  2007-05       Impact factor: 2.493

5.  The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study.

Authors:  J M Retera; M P Leers; M A Sulzer; P H Theunissen
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

6.  Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival.

Authors:  A Jawhari; S Jordan; S Poole; P Browne; M Pignatelli; M J Farthing
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

7.  Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein.

Authors:  K Yeung; P Janosch; B McFerran; D W Rose; H Mischak; J M Sedivy; W Kolch
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Authors:  K C Yeung; D W Rose; A S Dhillon; D Yaros; M Gustafsson; D Chatterjee; B McFerran; J Wyche; W Kolch; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 9.  Cancer-related inflammation.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica; Frances Balkwill
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

10.  Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse.

Authors:  Fahd Al-Mulla; Abdulla I Behbehani; Milad S Bitar; Govindarajulu Varadharaj; James J Going
Journal:  Mod Pathol       Date:  2006-05       Impact factor: 7.842

View more
  9 in total

1.  Downregulation of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.

Authors:  Ke Ke; Zhanwen Sun; Zhengjun Wang
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

2.  "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.

Authors:  Gary A Clawson; Gail L Matters; Ping Xin; Christopher McGovern; Eric Wafula; Claude dePamphilis; Morgan Meckley; Joyce Wong; Luke Stewart; Christopher D'Jamoos; Naomi Altman; Yuka Imamura Kawasawa; Zhen Du; Loren Honaas; Thomas Abraham
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

3.  SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.

Authors:  Lin Long; Xiao-Xiao Pang; Fei Lei; Jia-Sheng Zhang; Wei Wang; Lian-Di Liao; Xiu-E Xu; Jian-Zhong He; Jian-Yi Wu; Zhi-Yong Wu; Li-Dong Wang; De-Chen Lin; En-Min Li; Li-Yan Xu
Journal:  Cell Mol Life Sci       Date:  2018-02-10       Impact factor: 9.261

4.  Inhibition of glutathione metabolism attenuates esophageal cancer progression.

Authors:  Liang Peng; Ruixia Linghu; Demeng Chen; Jing Yang; Xiaoxue Kou; Xiang-Zhen Wang; Yi Hu; Yi-Zhou Jiang; Junlan Yang
Journal:  Exp Mol Med       Date:  2017-04-21       Impact factor: 8.718

5.  Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes.

Authors:  Heather L Lehman; Michal Kidacki; Douglas B Stairs
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

6.  Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model.

Authors:  Raghda T Abdel-Latif; Walaa Wadie; Yousra Abdel-Mottaleb; Dalaal M Abdallah; Nabila N El-Maraghy; Hanan S El-Abhar
Journal:  Saudi Pharm J       Date:  2021-12-31       Impact factor: 4.330

7.  NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation.

Authors:  Heather L Lehman; Michal Kidacki; Joshua I Warrick; Douglas B Stairs
Journal:  Oncotarget       Date:  2018-01-29

8.  Mcl-1 inhibitor suppresses tumor growth of esophageal squamous cell carcinoma in a mouse model.

Authors:  Jianqing Lin; Deqiang Fu; Yijun Dai; Jianguang Lin; Tianwen Xu
Journal:  Oncotarget       Date:  2017-06-28

9.  The β-glucan from Lentinus edodes suppresses cell proliferation and promotes apoptosis in estrogen receptor positive breast cancers.

Authors:  Hui Xu; Siwei Zou; Xiaojuan Xu
Journal:  Oncotarget       Date:  2017-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.